Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses | Zendy

Niven Mehra | Zendy; Karim Fizazi | Zendy; Johann S. de Bono | Zendy; Philippe Barthélémy | Zendy; Tanya B. Dorff | Zendy; Adam Stirling | Zendy; JeanPascal Machiels | Zendy; Davide Bimbatti | Zendy; Deepak Kilari | Zendy; Herlinde Dumez | Zendy; Consuelo Buttigliero | Zendy; Inge M. van Oort | Zendy; Elena Castro | Zendy; Hsiang-Chun Chen | Zendy; Nicola Di Santo | Zendy; Liza DeAnnuntis | Zendy; Cynthia G. Healy | Zendy; Giorgio V. Scagliotti | Zendy

Open Access

Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses

Author(s) -

Niven Mehra,

Karim Fizazi,

Johann S. de Bono,

Philippe Barthélémy,

Tanya B. Dorff,

Adam Stirling,

JeanPascal Machiels,

Davide Bimbatti,

Deepak Kilari,

Herlinde Dumez,

Consuelo Buttigliero,

Inge M. van Oort,

Elena Castro,

Hsiang-Chun Chen,

Nicola Di Santo,

Liza DeAnnuntis,

Cynthia G. Healy,

Giorgio V. Scagliotti

Publication year - 2022

Publication title -

the oncologist

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.176

H-Index - 164

eISSN - 1549-490X

pISSN - 1083-7159

DOI - 10.1093/oncolo/oyac172

Subject(s) - medicine , adverse effect , anemia , neutropenia , prostate cancer , leukopenia , nausea , population , febrile neutropenia , incidence (geometry) , surgery , cancer , toxicity , physics , environmental health , optics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research